Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer

• Victor Moreno,
• Andrew Gerry,
• Tom Holdich,
• Anthony J Olszanski,
• Ramaswamy Govindan,
• John V Heymach,
• Matthew J Frigault,
• Siddhartha Devarakonda,
• Melissa Johnson,
• Justin Gainor,
• Carlos Bachier,
• Natalie Hyland,
• Jean-Marc Navenot,
• Svetlana Fayngerts,
• Jane Bai,
• Elliot Norry,
• Robyn Broad,
• George R Blumenschein,
• Martin J Edelman,
• Bernard Doger de Spéville,
• Vincent K Lam,
• Zohar Wolchinsky,
• Dzmitry Batrakou,
• Melissa M Pentony,
• Joseph P Sanderson,
• Diane Marks,
• Paula M Fracasso

Affiliations

Victor Moreno

START Madrid‐FJD, Fundación Jiménez Díaz University Hospital, Madrid, Spain

Andrew Gerry

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

Tom Holdich

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

Anthony J Olszanski

Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Ramaswamy Govindan

Medical Oncology, Washington University School of Medicine, St Louis, Missouri, USA

John V Heymach

Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Matthew J Frigault

Bone Marrow Transplant & Cellular Therapy, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Siddhartha Devarakonda

Medical Oncology, Washington University School of Medicine, St Louis, Missouri, USA

Melissa Johnson

Lung Cancer Research and Drug Development, Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee, USA

Justin Gainor

Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA

Carlos Bachier

Hematology, Sarah Cannon Center for Blood Cancer at TriStar Centennial, Nashville, Tennessee, USA

Natalie Hyland

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

Jean-Marc Navenot

Adaptimmune, Philadelphia, Pennsylvania, USA

Svetlana Fayngerts

Adaptimmune, Philadelphia, Pennsylvania, USA

Jane Bai

Adaptimmune, Philadelphia, Pennsylvania, USA

Elliot Norry

Adaptimmune, Philadelphia, Pennsylvania, USA

Robyn Broad

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

George R Blumenschein

Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Martin J Edelman

Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

Bernard Doger de Spéville

START Madrid‐FJD, Fundación Jiménez Díaz University Hospital, Madrid, Spain

Vincent K Lam

Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA

Zohar Wolchinsky

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

Dzmitry Batrakou

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

Melissa M Pentony

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

Joseph P Sanderson

Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK

Diane Marks

Adaptimmune, Philadelphia, Pennsylvania, USA

Paula M Fracasso

Adaptimmune, Philadelphia, Pennsylvania, USA